Market Research Report
Infection Control Market by Product [Sterilization (Steam, Radiation, Sterilant, Indicators), Disinfection (Washer, UV Disinfection, Disinfectants), Endoscope Reprocessing, Protective Barriers], and End User - Global Forecast to 2027
|Published by||Meticulous Market Research Pvt. Ltd.||Product code||942392|
|Published||Content info||303 Pages
Delivery time: 1-2 business days
|Infection Control Market by Product [Sterilization (Steam, Radiation, Sterilant, Indicators), Disinfection (Washer, UV Disinfection, Disinfectants), Endoscope Reprocessing, Protective Barriers], and End User - Global Forecast to 2027|
|Published: June 15, 2020||Content info: 303 Pages||
The infection control market is expected to grow at a CAGR of 13.3% from 2020 to 2027 to reach $58.2 billion by 2027.
Succeeding an extensive secondary and primary research and in-depth analysis of the market scenario, the report carries out the analysis of the key industry drivers, restraints, opportunities, and challenges. The growth in the infection control market is mainly attributed to the growing incidences of hospital-acquired infections, rising number of surgical procedures, increasing incidence of chronic diseases associated with growing geriatric population, and growing medical device reprocessing industry. In addition, the growing number of medical device and pharmaceutical industries in emerging economies, and increasing use of e-beam sterilization provide significant growth opportunities for vendors across the globe.
The infection control market study by Meticulous Research® presents historical market data in terms of value (2018, and 2019), estimated current data (2020), and forecasts for 2027 - by product, and end user. The study also evaluates industry competitors and analyzes the market at regional and country level.
On the basis of product type, the cleaning & disinfection products segment is estimated to account for the largest share of the overall infection control market in 2020. However, the endoscope reprocessing products segment is expected to grow at the fastest growth rate during the forecast year due to the growing importance of diagnostic and therapeutic endoscopy procedures, concerns regarding surgical wound-associated infections, and technological advancement in the medical field.
On the basis of end user, the hospitals & clinics segment is estimated to command the largest share of the overall infection control market in 2020. The large share of this segment is mainly attributed to the growing incidence of hospital acquired infections (HAIs) and rising number of surgical procedures. Apart from these factors, the increasing chronic diseases associated with aging population, growing awareness among people for quality care, rising number of hospitalization due to sudden outbreak of COVID-19, and focus on reducing the healthcare burden caused due to HAIs supported the dominance of this segment.
An in-depth analysis of the geographical scenario of the infection control market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) along with the coverage of major countries in each region. North America is estimated to dominate the overall infection control market in 2020, followed by Europe, and Asia Pacific. However, Asia Pacific region is expected to grow at the fastest CAGR during the forecast period, which is mainly attributed to the factors such as accelerated economic growth of many countries, growing government focus on healthcare sector, rising prevalence of infectious diseases including COVID-19, and government initiatives for boosting production of infection control products.
The key players operating in the global infection control market are STERIS plc. (U.S.), Cantel Medical Corp. (U.S.), Getinge AB (Sweden), Ecolab (U.S.), 3M (U.S.), Advanced Sterilization Products (U.S.), MMM Group (Germany), MATACHANA Group (Spain), Belimed (Switzerland), MELAG Medizintechnik GmbH & Co. KG (Germany), Merck KGaA (Germany), DORSAN (Spain), BiOZEEN (India), Pall Corporation (U.S.), Hu-Friedy Mfg. Co., LLC (U.S.), PMS TIbbiCihazlarTeknolojisi San. ve Tic. A.S. (Turkey), Ultrawave (U.K.), SharperTek (U.S.), Steelco S.p.A. (Italy), XENEX Disinfection Systems (U.S.), Alpha-Cure Ltd (U.K.), Tru-D SmartUVC (U.S.), Lumalier (U.S.), LIT Company (The Netherlands), Spire Integrated Solutions (U.S.), Whiteley Corporation (Australia), Metrex Research, LLC. (U.S.), Certol International LLC. (U.S.), BODE Chemie GmbH (Germany), NEX MEDICAL ANTISEPTICS Srl (Italy), PSK Pharma Pvt.Ltd (India), Dr. Schumacher GmbH (Germany), Dr. Schumacher GmbH (Germany), ACTO GmbH (Germany), Medisept (Poland), Biotrol (U.S.), ARC Healthcare Solutions Inc. (Canada), Wassenburg Medical B.V. (Netherlands), Guardian (England), Medline International Two Australia Pty Ltd (Australia), Shandong Delta-Medi Co., Ltd. (China), Tronex International, Inc. (U.S.), Shandong Delta-Medi Co., Ltd. (China), Kilang MEDICOS (Malaysia), priMED Medical Products, Inc. (Canada), IREMA (Ireland), Amray Radiation Protection (Ireland), and Ansell (U.S.) among others.
Infection Control Market, by Product
Infection Control Market, by End User
Infection Control Market, by Geography